Novo Nordisk's CagriSema Delivers 12.4% Weight Loss, Beats Lilly's Tirzepatide in Trial Written By sheeba farhat22 Sept 2026 9:30 PM ISTBengaluru: Novo Nordisk said on Monday its next-generation experimental drug, CagriSema, delivered an estimated average weight loss of 12.4% in a...
Novo Nordisk Plans 5+ Blockbuster Launches by 2030 as Semaglutide Patent Expiry Looms Written By sheeba farhat22 Sept 2026 9:17 PM ISTLondon: Novo Nordisk aims to launch more than five blockbuster drugs by 2030 and to deliver more than 150 billion Danish crowns (USD 23 billion) in...
Novo Nordisk, Orbis Ink Up to USD 1.4 Bn Deal to Develop Oral Cardiometabolic Therapies Written By sheeba farhat18 Sept 2026 9:35 PM ISTBengaluru: Orbis Medicines said on Thursday it had signed a drug discovery and licensing agreement worth up to USD 1.4 billion with Novo Nordisk to...
Novo Nordisk Adopts 'Novo' Name for Day-to-Day Business Amid Eli Lilly Challenge Written By sheeba farhat15 Sept 2026 10:09 PM ISTLondon: Novo Nordisk is changing its day-to-day name to 'Novo', and taking a new approach to company culture as it looks to claw back ground in the...
Eli Lilly Gains Over 30% Share of New US Oral Obesity Patients With Foundayo, Challenges Wegovy Written By sheeba farhat15 Sept 2026 9:23 PM ISTBengaluru: Eli lilly on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early...
Novo Nordisk's Wegovy Gets China Approval for MASH, First GLP-1 RA Approved for Liver Disease Written By sheeba farhat13 Sept 2026 10:00 AM ISTStockholm: Denmark's Novo Nordisk said on Thursday its blockbuster weight-loss drug Wegovy had been approved in China as the first GLP-1 RA class...
USFDA Approves Eli Lilly's Mounjaro to Cut Heart Attack, Stroke Risk in High-Risk Type 2 Diabetes Patients Written By sheeba farhat29 Aug 2026 8:06 PM ISTBengaluru: Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to reduce the chances of heart attack or stroke in adults...
Huawei Eyes AI Drug Development, Clinical Practice Partnerships With Chinese Pharma Firms Written By sheeba farhat29 Aug 2026 7:41 PM ISTShanghai: Chinese technology conglomerate Huawei plans to expand its AI cooperation with local pharmaceutical firms into drug development and...
US Employers Reconsider GLP-1 Coverage as Healthcare Costs Set to Rise 9.2% in 2027: Survey Written By Parthika Patel27 Aug 2026 2:15 PM ISTNew York: About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see rising healthcare costs,...
Eli Lilly Launches Foundayo Weight-Loss Pill in UK, First European Market for Oral Treatment Written By sheeba farhat26 Aug 2026 10:30 AM ISTLondon: Eli Lilly has launched its pill, Foundayo, in the UK for weight management and type 2 diabetes, it said on Monday, making Britain the first...
Celon Pharma's Generic Semaglutide Reduzek Matches Ozempic, Wegovy in Bioequivalence Study Written By sheeba farhat22 Aug 2026 9:00 PM ISTGdansk: Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo Nordisk's Wegovy and Ozempic, matched the blockbuster...
UK First in Europe to Approve Eli Lilly's Foundayo Pill for Weight Management, Type 2 Diabetes Written By MD Bureau12 Aug 2026 10:00 PM ISTBengaluru: Britain's medicines regulator on Monday authorised Eli Lilly's pill, Foundayo, for weight management and type 2 diabetes, making it the...
